Panasonic's Continuous Sustainable Seafood Efforts in Its Corporate Cafeterias Win "Japan Sustainable Seafood Award" Champion
28.11.2019 07:14:00 EET | Business Wire | Press release
On November 7, 2019, Panasonic's efforts to transform consumer behavior and contribute to the achievement of SDGs (*1) by promoting sustainable seafood in its corporate cafeterias won the Initiative Award Champion at the inaugural "Japan Sustainable Seafood Award" during the Tokyo Sustainable Seafood Symposium 2019.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191127005693/en/
Sustainable Seafood Award Ceremony (Photo: Business Wire)
[Video] Protect Marine Life with Corporate Cafeterias - Sustainable Seafood Initiatives [Panasonic]
https://youtu.be/lnPtiBO12ok
The Japan Sustainable Seafood Award is given to people, organizations, and projects that contribute to the promotion of sustainable seafood and enhance the sustainability of the fisheries industry in Japan, and is comprised of the Initiative and Collaboration Award categories. Panasonic's project was selected as one of the finalists for the Initiative Award and ultimately awarded as the Champion.
From March 2018, Panasonic has been serving MSC, ASC certified (*2) sustainable seafood in its cafeterias. MSC and ASC certifications are the only 2 certifications recognized by WWF, and Panasonic became the first company to continuously serve such sustainable seafood in its corporate cafeterias. As of November 20, 2019, sustainable seafood has been adopted at 27 cafeterias, and by the end of FY2020, Panasonic is aiming to serve sustainable seafood in approximately 100 corporate cafeterias in Japan.
Panasonic became the Champion for taking the initiative to adopt sustainable seafood in its corporate cafeterias and for promoting CoC (*3) certification among the food service industry. Its efforts were also highly recognized because of the significant social impact it can have through its numerous employees and for the know-how it has provided to other companies.
Through these efforts, Panasonic will continue to contribute to achieving SDGs by enhancing awareness for sustainable seafood and by changing consumer behavior. More specifically, through its activities in corporate cafeterias, Panasonic will communicate to its employees the critical situation of fishery resources, and augment employee awareness for MSC and ASC certification, so that they will change their consumer behavior and begin choosing sustainable seafood even outside their workplace.
*1 SDGs refer to the 2030 Agenda for Sustainable Development comprised of 17 Sustainability Development Goals unanimously adopted at the United Nations in 2015. This initiative specifically addresses Goal 14: Conserve and sustainably use the oceans, seas and marine resources.
*2 MSC (Marine Stewardship Council) certifies sustainable and appropriately managed fisheries, while ASC (Aquaculture Stewardship Council) certifies responsible aquaculture practices that minimize harm to the environment and society. In both cases, products and suppliers are audited against stringent standards by a third-party certifying organization.
*3 Abbreviation for Chain of Custody, which refers to processing and distribution control. It is a system that ensures the traceability of products by following the route they have taken in their distribution and processing in order to prevent contamination of uncertified seafood into certified seafood.
About Panasonic
Panasonic Corporation is a worldwide leader in the development of diverse electronics technologies and solutions for customers in the consumer electronics, housing, automotive, and B2B businesses. The company, which celebrated its 100th anniversary in 2018, has expanded globally and now operates 582 subsidiaries and 87 associated companies worldwide, recording consolidated net sales of 8.003 trillion yen for the year ended March 31, 2019. Committed to pursuing new value through innovation across divisional lines, the company uses its technologies to create a better life and a better world for its customers. To learn more about Panasonic: https://www.panasonic.com/global.
Source: https://news.panasonic.com/global/topics/2019/73623.html
Related Links
Environment: Biodiversity Conservation | Panasonic
https://www.panasonic.com/global/corporate/sustainability/eco/biodiversity.html
Sustainability | Panasonic
https://www.panasonic.com/global/corporate/sustainability.html
Sustainability Data Book 2019 | Panasonic
https://www.panasonic.com/global/corporate/sustainability/downloads.html
[Feature Story] Conserve Marine Environment through Its Corporate Cafeterias - Panasonic's Challenge to Propagating Sustainable Seafood (Aug 02, 2019)
https://news.panasonic.com/global/stories/2019/70462.html
[Video] Protect Marine Life with Corporate Cafeterias - Sustainable Seafood Initiatives [Panasonic]
https://youtu.be/lnPtiBO12ok
[Video Review] Protect Marine Life with Corporate Cafeterias - Sustainable Seafood Initiatives (Jul 04, 2019)
https://news.panasonic.com/global/stories/2019/69670.html
Creating a Better World Through "Sustainable Development Goals" (Nov 01, 2018)
https://news.panasonic.com/global/stories/2018/62660.html
Sustainable Development Knowledge Platform - United Nations
https://sustainabledevelopment.un.org/
Japan Sustainable Seafood Award - Tokyo Sustainable Seafood Symposium
https://sustainableseafoodnow.com/2019/en/award/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191127005693/en/
Contact information
Panasonic Corporation
Global Communications Department
Global PR Office
Click here to go to Media Contact form
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
U.S. FDA Grants Priority Review to BeOne Medicines’ BRUKINSA Combination in First-Line Mantle Cell Lymphoma4.11.2026 16:13:00 EET | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review to the supplemental New Drug Application (sNDA) for BRUKINSA® (zanubrutinib) in combination with rituximab for the treatment of adult patients with previously untreated mantle cell lymphoma (MCL). The application is supported by data from the pivotal Phase 3 MANGROVE study, in which this chemotherapy-free regimen significantly reduced the risk of disease progression or death compared with standard chemoimmunotherapy. Full results from the MANGROVE study will be presented during the Plenary Scientific Session at the 68th American Society of Hematology (ASH) Annual Meeting on December 13, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261103605806/en/ BeOne Medicines' flagship U.S. manufacturing and clinical R&D facility at the P
Incyte to Present New Data Highlighting Progress Across its Hematology Portfolio at ASH 20264.11.2026 16:00:00 EET | Press release
Incyte (Nasdaq:INCY) today announced that new data highlighting progress across its hematology portfolio will be presented across more than 30 abstracts at the 2026 American Society of Hematology (ASH) Annual Meeting, to beheld December 12 – 15, 2026, in New Orleans. “Our ASH presentations demonstrate meaningful progress across our Hematology portfolio to advance novel treatment approaches for people with serious hematologic conditions,” said Pablo J. Cagnoni, M.D., President, Incyte and Global Head of Research and Development. "We are particularly encouraged by the continued clinical progress of INCA033989 in myelofibrosis (MF) and essential thrombocythemia (ET) and the data for latarcibart in von Willebrand disease (VWD) - data that support our goal of advancing differentiated medicines with the potential to meaningfully improve outcomes for patients." Details on key data presentations at ASH include: Oral Presentations INCA033989 (mutCALR) In JAK-Inhibitor Naive Patients with Myelof
Rimini Street Awarded CANUT Third-Party Maintenance Framework Agreement4.11.2026 16:00:00 EET | Press release
Rimini Street, Inc. (Nasdaq: RMNI), the Software Support and Agentic AI ERP Company™ and the leading third-party support provider for Oracle, SAP and VMware software, today announced that it had been selected as the awardee of the third-party support service lots (TMA) by CANUT, the French public purchasing center specializing in digital technology and telecommunications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261104431817/en/ Rimini Street Awarded CANUT Third-Party Maintenance Framework Agreement Eligible public organizations subject to the French Public Procurement Code can now benefit from Rimini Street services for their Oracle, SAP, VMware and IBM environments, without having to go through a lengthy individual tender process. Through Rimini Support™, organizations gain access to a support alternative enabling them to significantly reduce their historical support costs, improve service quality and support respons
Zenitar Announces Initiation of International Randomized Study of Flonoltinib Maleate in Patients with Myelofibrosis and Related American Society of Hematology 2026 Meeting Presentations4.11.2026 16:00:00 EET | Press release
Chengdu Zenitar Biomedical Technology Co., Ltd. (Zenitar) is developing flonoltinib maleate (FM), a first-in-class oral JAK2/FLT3/CDK6 inhibitor for myeloproliferative neoplasms (MPNs), including myelofibrosis (MF) and polycythemia vera (PV). Zenitar launched randomized Phase 2 FM-MF-02 (NCT07750574) in the US, Canada and Brazil to select Phase 3 dose for JAKi-naïve and refractory MF. Randomized FMF-02 (NCT06457425) met its week-24 endpoints: superior SVR35 and TSS50 with FM 50/100mg versus ruxolitinib; previous data presented orally at ASH24 (#486) and ASH25 (#908). ASH 2026 presence covers FMF-02 long-term follow-up (oral presentation, #411, December 12, 4:30pm) and refractory PV Phase 2 data (poster, #3765, December 13, 6pm), both in Session 634. “Over the 15 years since the initial FDA approval of Ruxolitinib, JAKi have markedly improved the prognosis of many patients with MF. The long-term data show significant room for improvement for this key therapeutic class in terms of both e
Trained Therapeutix Discovery Appoints Andrew Glass as Chief Executive Officer4.11.2026 15:41:00 EET | Press release
Trained Therapeutix Discovery ("TTxD"), a pioneering immunotherapy company founded by the Jean Boulle Group and the Heritage Group, which is developing nanomedicines to regulate innate immunity, announces the appointment of Andrew Glass as Chief Executive Officer with immediate effect. Mr. Glass has more than 20 years of leadership experience in the life sciences industry as Chief Executive Officer of Vivasure Medical and previously from over 15 years in senior leadership roles at Abbott. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261104178009/en/ Andrew Glass, CEO, TTxD Following the previously announced changes to the Company’s Board earlier this year, Mr. Glass joins the Company as it transitions from preclinical stage to being a clinical-stage organisation. His expertise in developmental strategy, financing and organisational growth is focussed on expediting the delivery of the aims associated with TTxD’s proprietary
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom